Skip to content

Press Releases

Date Title
08/07/2020 Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases
23/06/2020 Illumina Accelerator Welcomes First Global Cohort of Genomics Startups
17/06/2020 Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale
16/06/2020 Illumina Inc. Announces that U.S. Federal Court Issues Preliminary Injunction Against BGI Companies
09/06/2020 Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test
18/05/2020 Illumina, Inc. and the Illumina Corporate Foundation Commit $10 Million to COVID-19 Response and Research
04/05/2020 Illumina Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development
30/04/2020 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020
28/04/2020 Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance
16/04/2020 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19
14/04/2020 Illumina Reports Preliminary Revenue for First Quarter of Fiscal Year 2020
27/02/2020 Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.
12/02/2020 Illumina to Webcast Upcoming Investor Conference Presentations
06/02/2020 Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors
29/01/2020 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019
13/01/2020 Illumina to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Wednesday, January 29, 2020
13/01/2020 Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics
13/01/2020 Illumina and Roche Partner to Broaden Patient Access to Genomic Testing
10/01/2020 Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom
02/01/2020 Illumina and Pacific Biosciences Announce Termination of Merger Agreement